Biotech Acquisition Company Unit
BIOTU
BIOTU was delisted on the 2nd of February, 2023.
59 hedge funds and large institutions have $118M invested in Biotech Acquisition Company Unit in 2021 Q1 according to their latest regulatory filings, with 59 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$11.8M |
| 2 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
+$11.3M |
| 3 |
GCL
Glazer Capital LLC
New York
|
+$10.8M |
| 4 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$10.3M |
| 5 |
LA
Linden Advisors
New York
|
+$6.98M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GF
51
Gabelli Funds
Rye,
New York
| $243K | +$253K | +24,600 | New |
|
|
OCAM
52
Owl Creek Asset Management
New York
| $198K | +$206K | +20,000 | New |
|
|
LCM
53
Landscape Capital Management
Englewood,
New Jersey
| $123K | +$128K | +12,416 | New |
|
|
AA
54
Ancora Advisors
Cleveland,
Ohio
| $100K | +$104K | +10,100 | New |
|
|
VCM
55
Vivaldi Capital Management
Chicago,
Illinois
| $99K | +$103K | +10,000 | New |
|
56
Morgan Stanley
New York
| $98K | +$102K | +9,922 | New |
|
|
BCM
57
Basso Capital Management
Stamford,
Connecticut
| $41K | +$43.1K | +4,193 | New |
|
58
UBS Group
Zurich,
Switzerland
| $24K | +$24.8K | +2,411 | New |
|
59
Walleye Capital
New York
| $1.19K | +$1.23M | +120,000 | New |
|
BIOTU Hedge Fund Activity: Q1 2021 in Review
59 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Biotech Acquisition Company Unit (BIOTU) for Q1 2021, worth a combined $118M.
Buyers outnumbered sellers: 59 funds opened new BIOTU positions and 0 closed out — a net gain of 59 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Aristeia Capital, opening a new position worth an estimated $11.8M.
- 59 institutional investors held Biotech Acquisition Company Unit (BIOTU) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $118M of Biotech Acquisition Company Unit stock for Q1 2021.
- 59 funds opened new Biotech Acquisition Company Unit positions in Q1 2021 and 0 closed out, a net change of +59 holders.
- The largest Biotech Acquisition Company Unit buyer in Q1 2021 was Aristeia Capital, an estimated $11.8M added.
Based on aggregated 13F filings for Q1 2021.